Latest Scripps Research Institute Stories
Proceedings of the National Academy of Sciences Study Shows Ability to Create Therapeutics Targeting Critical MYC Regulator for Potential Treatment of Cancer SAN DIEGO, Aug.
Publication in Science Unveils Novel, Diverse and Separate Biological Functions That Can Be Harnessed Therapeutically to Mediate a Wide Range of Human Disease SAN DIEGO and HONG KONG,
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have discovered a surprising new role for a pair of compounds—which have the potential to alter circadian rhythm, the complex physiological process that responds to a 24-hour cycle of light and dark and is present in most living things.
PHILADELPHIA, June 24, 2014 /PRNewswire-USNewswire/ -- Twenty-two outstanding early-career researchers were named Pew Scholars in the Biomedical Sciences today by The Pew Charitable Trusts.
LA JOLLA, Calif., May 23, 2014 /PRNewswire-USNewswire/ -- The California Institute for Biomedical Research (Calibr) has received a Translation Award from the Wellcome Trust to develop a novel
Chemists at The Scripps Research Institute (TSRI) have determined the correct structure of a highly promising anticancer compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials in cancer patients.
PASADENA, Calif., May 19, 2014 /PRNewswire/ -- Meditope Biosciences, Inc., a biotechnology company developing novel
LA JOLLA, Calif., May 16, 2014 /PRNewswire-USNewswire/ -- Mice crippled by an autoimmune disease similar to multiple sclerosis (MS) regained the ability to walk and run after a team of researchers
LA JOLLA, Calif., May 12, 2014 /PRNewswire-USNewswire/ -- The California Institute for Biomedical Research (Calibr) has received a grant from the Bill & Melinda Gates Foundation to develop
First example of in vivo replication of a synthetic DNA base pair published in Nature SAN DIEGO, May 7, 2014 /PRNewswire/ -- Synthorx Inc.